Hofseth Biocare ASA (HBC) — Cash Flow Quality Index
Latest as of June 2023:
0.55x
Hofseth Biocare ASA (HBC) has a Cash Flow Quality Index of 0.55x as of June 2023. Operating cash flow of Nkr3.16 Million is below net income of Nkr5.76 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore Hofseth Biocare ASA long-term investment allocation to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
0.55x
Operating CF / Net Income
Operating Cash Flow
Nkr3.16 Million
NOK
Net Income
Nkr5.76 Million
NOK
Data as of
Jun 2023
Most recent filing
Annual Cash Flow Quality Index for Hofseth Biocare ASA (None–None)
Year-by-year earnings quality comparison for Hofseth Biocare ASA. For live market cap and the full company financial profile, see HBC company net worth.
| Year | Quality Index | Operating CF (NOK) | Net Income | YoY Change |
|---|
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.